Balance Sheet EXEO Group, Inc.

Equities

1951

JP3254200003

Construction & Engineering

Market Closed - Japan Exchange Other stock markets 01:30:00 2026-02-13 EST			5-day change	1st Jan Change
2,775.00 ^JPY	-1.18%		+2.76%	+6.77%

02-06	Exeo Group Inc - to buy back up to 0.98% own shares worth 4 billion yen	RE
02-06	EXEO Group, Inc. Reports Earnings Results for the Nine Months Ended December 31, 2025	CI

238add229dd.KqYiD98WMa56ujeD54hcA0xAwtiMEKDeia7z1hbKqf0.Htd1a-tacJstz2DAj7sKW3orkp7fd_mr3deR4U7n7LFQ3Hdjhjt0-xTzQA

Published financial data: EXEO GROUP, INC.

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: March	2021	2022	2023	2024	2025
Revenues	573B	595B	628B	614B	671B
Total Revenues	573B	595B	628B	614B	671B
Cost of Goods Sold, Total	497B	511B	546B	525B	570B
Gross Profit	75.86B	84.32B	81.84B	89.16B	100B
Selling General & Admin Expenses, Total	39.24B	41.94B	49.28B	55.04B	58.02B
Provision for Bad Debts	-	-	-	585M	-
Other Operating Expenses, Total	39.24B	41.94B	49.28B	55.62B	58.02B
Operating Income	36.62B	42.38B	32.55B	33.54B	42.46B
Interest Expense, Total	-148M	-226M	-640M	-797M	-1.05B
Interest And Investment Income	1.14B	846M	877M	998M	932M
Net Interest Expenses	988M	620M	237M	201M	-118M
Currency Exchange Gains (Loss)	483M	1.88B	1.05B	2.73B	1.43B
Other Non Operating Income (Expenses)	822M	1.02B	-69M	452M	243M
EBT, Excl. Unusual Items	38.92B	45.9B	33.77B	36.92B	44.02B
Gain (Loss) On Sale Of Investments	478M	-1.1B	2.52B	3.45B	1.05B
Gain (Loss) On Sale Of Assets	-325M	-208M	1.13B	-	-
Asset Writedown	-406M	-471M	-	-4.2B	-515M
Other Unusual Items	-	-	1M	-	-550M
EBT, Incl. Unusual Items	38.66B	44.11B	37.43B	36.17B	44.01B
Income Tax Expense	14.34B	15.69B	14.43B	15.79B	17.08B
Earnings From Continuing Operations	24.33B	28.42B	23B	20.39B	26.93B
Net Income to Company	24.33B	28.42B	23B	20.39B	26.93B
Minority Interest	-137M	-652M	-769M	-329M	-77M
Net Income - (IS)	24.19B	27.77B	22.23B	20.06B	26.86B
Net Income to Common Incl Extra Items	24.19B	27.77B	22.23B	20.06B	26.86B
Net Income to Common Excl. Extra Items	24.19B	27.77B	22.23B	20.06B	26.86B
Per Share Items
Net EPS - Basic	108.66	125.32	102.49	94.76	128.97
Basic EPS - Continuing Operations	108.66	125.32	102.49	94.76	128.97
Basic Weighted Average Shares Outstanding	223M	222M	217M	212M	208M
Net EPS - Diluted	108.52	125.24	102.45	94.73	128.92
Diluted EPS - Continuing Operations	108.52	125.24	102.45	94.73	128.92
Diluted Weighted Average Shares Outstanding	223M	222M	217M	212M	208M
Normalized Basic EPS	108.64	126.53	93.75	107.46	131.76
Normalized Diluted EPS	108.5	126.44	93.72	107.42	131.71
Dividend Per Share	41	47	51	60	63
Payout Ratio	37.38	34.02	50.56	58.81	47.61
Supplemental Items
EBITDA	45.28B	51.75B	44.85B	47.02B	56.98B
EBITA	38.49B	44.34B	36.15B	36.88B	45.54B
EBIT	36.62B	42.38B	32.55B	33.54B	42.46B
Effective Tax Rate - (Ratio)	37.08	35.58	38.54	43.64	38.8
Normalized Net Income	24.19B	28.03B	20.34B	22.75B	27.44B
Non-Cash Pension Expense	-1.24B	-1.47B	-1.04B	-1.48B	-1.86B
Supplemental Operating Expense Items
Research And Development Expense From Footnotes	297M	637M	624M	486M	777M

Fiscal Period: March	2021	2022	2023	2024	2025
Assets
Cash And Equivalents	42.78B	54.86B	51.45B	48.25B	40.01B
Short Term Investments	910M	750M	263M	-	-
Total Cash And Short Term Investments	43.7B	55.61B	51.72B	48.25B	40.01B
Accounts Receivable, Total	205B	218B	232B	236B	279B
Total Receivables	205B	218B	232B	236B	279B
Inventory	43.56B	46.19B	53.88B	53.42B	57.72B
Deferred Tax Assets Current	-	-	-	-	-
Other Current Assets, Total	8.39B	7.28B	15.65B	10.64B	10.93B
Total Current Assets	300B	327B	354B	348B	388B
Net Property Plant And Equipment	113B	127B	136B	146B	156B
Long-term Investments	67.79B	62.62B	59.66B	67.86B	65.81B
Goodwill	5.95B	9.21B	15.11B	13.87B	15.12B
Other Intangibles, Total	4.23B	4.54B	8B	8.8B	9.96B
Deferred Tax Assets Long-Term	-	5.69B	5.82B	7.31B	8.16B
Other Long-Term Assets, Total	1M	1M	2M	2M	2M
Total Assets	492B	536B	578B	592B	643B
Liabilities
Accounts Payable, Total	74.89B	69.58B	75.03B	73.41B	83.03B
Accrued Expenses, Total	5.46B	3.11B	3.06B	3.32B	3.76B
Short-term Borrowings	19.51B	30.76B	28.75B	29.19B	52.13B
Current Portion of Long-Term Debt	10B	-	-	10B	-
Current Income Taxes Payable	6.77B	10.71B	4.53B	10.14B	11.71B
Unearned Revenue Current, Total	8.08B	9.4B	12.69B	12.59B	15.91B
Other Current Liabilities	31.5B	34.21B	35.04B	39.06B	40.06B
Total Current Liabilities	156B	158B	159B	178B	207B
Long-Term Debt	26.84B	48.01B	83.63B	63.19B	77.06B
Pension & Other Post Retirement Benefits	8.61B	10.31B	10.86B	10.55B	10.77B
Deferred Tax Liability Non Current	8.33B	9.22B	10.82B	14.5B	13.59B
Other Non Current Liabilities	2.7B	3.27B	5.6B	6.62B	7.69B
Total Liabilities	203B	229B	270B	273B	316B
Common Stock, Total	6.89B	6.89B	6.89B	6.89B	6.89B
Additional Paid In Capital	49.84B	48.55B	28.91B	22.09B	14.54B
Retained Earnings	226B	245B	256B	265B	279B
Treasury Stock	-13.22B	-13.06B	-5.85B	-4.53B	-2.78B
Comprehensive Income and Other	16.11B	16.29B	17.1B	24.21B	23.71B
Total Common Equity	286B	304B	303B	313B	321B
Minority Interest	2.97B	3.5B	4.58B	5.85B	5.64B
Total Equity	289B	307B	308B	319B	327B
Total Liabilities And Equity	492B	536B	578B	592B	643B
Supplemental Items
ECS Total Shares Outstanding on Filing Date	222M	219M	213M	210M	207M
ECS Total Common Shares Outstanding	222M	221M	214M	210M	207M
Book Value / Share	1.29K	1.37K	1.42K	1.49K	1.55K
Tangible Book Value	276B	290B	280B	291B	296B
Tangible Book Value Per Share	1.24K	1.31K	1.31K	1.38K	1.43K
Total Debt	56.35B	78.76B	112B	102B	129B
Net Debt	12.65B	23.15B	60.66B	54.14B	89.18B
Debt Equivalent of Unfunded Proj. Benefit Obligation	-13.68B	-14.21B	-11.31B	-17.38B	-17.36B
Minority Interest, Total (Incl. Fin. Div)	2.97B	3.5B	4.58B	5.85B	5.64B
Inventories - Raw Materials, Total	3.35B	5.09B	9.46B	8.8B	9.28B
Inventories - Work In Process, Total	39.8B	39.87B	43.08B	43.08B	43.21B
Inventories - Finished Goods, Total	407M	1.23B	1.34B	1.54B	5.23B
Full Time Employees	14.37K	15.85K	16.77K	17.06K	17.26K
Accumulated Allowance for Doubtful Accounts (Supple)	80M	68M	83M	95M	186M
Order Backlog	289B	290B	-	-	-

Fiscal Period: March	2021	2022	2023	2024	2025
Net Income	38.66B	44.11B	37.43B	36.18B	44.01B
Depreciation & Amortization - CF	6.79B	7.41B	8.7B	10.14B	11.44B
Amortization of Goodwill and Intangible Assets - (CF)	1.86B	1.96B	3.6B	3.34B	3.08B
Depreciation & Amortization, Total	8.65B	9.37B	12.3B	13.48B	14.51B
(Gain) Loss From Sale Of Asset	407M	456M	-930M	-195M	-164M
(Gain) Loss on Sale of Investments - (CF)	-473M	-416M	-1.87B	-3.45B	-1.02B
Other Operating Activities, Total	-16.97B	-11.08B	-20.64B	-9.11B	-16.34B
Change In Accounts Receivable	-37.38B	5.36B	-7.12B	-2.19B	-42.56B
Change In Inventories	-960M	-12.32B	-3.7B	769M	-3.95B
Change In Accounts Payable	14.55B	-7.79B	1.61B	-926M	8.32B
Change in Other Net Operating Assets	-191M	-1.27B	-11.6B	7.34B	4.03B
Cash from Operations	6.3B	26.41B	5.48B	41.9B	6.84B
Capital Expenditure	-8.84B	-17.95B	-11.36B	-17.34B	-15.76B
Sale of Property, Plant, and Equipment	90M	880M	2.43B	1.68B	1B
Cash Acquisitions	-77M	-4.82B	-5.69B	-1.48B	-2.49B
Divestitures	-20M	-	-356M	-	-
Sale (Purchase) of Intangible assets	-1.32B	-2.22B	-2.38B	-2.43B	-2.9B
Investment in Marketable and Equity Securities, Total	788M	4.45B	4.1B	5.89B	2.56B
Net (Increase) Decrease in Loans Originated / Sold - Investing	-100M	-365M	109M	6M	-60M
Other Investing Activities, Total	232M	-359M	-194M	81M	-787M
Cash from Investing	-9.25B	-20.39B	-13.33B	-13.59B	-18.43B
Short Term Debt Issued, Total	11.02B	10.86B	-	-	-
Long-Term Debt Issued, Total	2.13B	22.56B	36.72B	3.6B	42.38B
Total Debt Issued	13.15B	33.42B	36.72B	3.6B	42.38B
Short Term Debt Repaid, Total	-	-	-3.9B	-11.41B	-2.12B
Long-Term Debt Repaid, Total	-3.21B	-13.72B	-2.71B	-2.44B	-15.12B
Total Debt Repaid	-3.21B	-13.72B	-6.61B	-13.85B	-17.24B
Issuance of Common Stock	1.42B	1.24B	22M	68M	315M
Repurchase of Common Stock	-3.01B	-5B	-7.5B	-6B	-6B
Common Dividends Paid	-9.04B	-9.45B	-11.24B	-11.8B	-12.79B
Common & Preferred Stock Dividends Paid	-9.04B	-9.45B	-11.24B	-11.8B	-12.79B
Other Financing Activities, Total	-1.06B	-1.46B	-8.09B	-2.58B	-3.78B
Cash from Financing	-1.75B	5.02B	3.3B	-30.56B	2.89B
Foreign Exchange Rate Adjustments	-67M	590M	1.7B	-529M	684M
Miscellaneous Cash Flow Adjustments	-1M	849M	-676M	-	2M
Net Change in Cash	-4.77B	12.48B	-3.52B	-2.77B	-8.02B
Supplemental Items
Cash Interest Paid	164M	202M	628M	460M	1.32B
Cash Income Tax Paid (Refund)	16.95B	11.11B	20.64B	9.45B	16.05B
Levered Free Cash Flow	-4.29B	1.33B	-9.11B	24.77B	-10.43B
Unlevered Free Cash Flow	-4.2B	1.47B	-8.71B	25.27B	-9.77B
Change In Net Working Capital	25.58B	14.21B	27.62B	-10.59B	32.17B
Net Debt Issued / Repaid	9.94B	19.7B	30.11B	-10.24B	25.14B

Fiscal Period: March	2021	2022	2023	2024	2025
Profitability
Return on Assets	4.89	5.16	3.65	3.58	4.3
Return on Total Capital	6.92	7.25	5.05	4.98	6.05
Return On Equity %	8.7	9.54	7.48	6.5	8.34
Return on Common Equity	8.75	9.42	7.33	6.51	8.47
Margin Analysis
Gross Profit Margin %	13.23	14.18	13.04	14.52	14.98
SG&A Margin	6.84	7.05	7.85	8.96	8.65
EBITDA Margin %	7.9	8.7	7.15	7.66	8.49
EBITA Margin %	6.71	7.45	5.76	6.01	6.79
EBIT Margin %	6.39	7.12	5.19	5.46	6.33
Income From Continuing Operations Margin %	4.24	4.78	3.66	3.32	4.01
Net Income Margin %	4.22	4.67	3.54	3.27	4
Net Avail. For Common Margin %	4.22	4.67	3.54	3.27	4
Normalized Net Income Margin	4.22	4.71	3.24	3.7	4.09
Levered Free Cash Flow Margin	-0.75	0.22	-1.45	4.03	-1.55
Unlevered Free Cash Flow Margin	-0.73	0.25	-1.39	4.11	-1.46
Asset Turnover
Asset Turnover	1.22	1.16	1.13	1.05	1.09
Fixed Assets Turnover	5.19	4.95	4.78	4.36	4.45
Receivables Turnover (Average Receivables)	3.09	2.82	2.79	2.62	2.61
Inventory Turnover (Average Inventory)	11.56	11.38	10.91	9.78	10.26
Short Term Liquidity
Current Ratio	1.92	2.07	2.22	1.96	1.88
Quick Ratio	1.59	1.73	1.79	1.6	1.54
Operating Cash Flow to Current Liabilities	0.04	0.17	0.03	0.24	0.03
Days Sales Outstanding (Average Receivables)	117.96	129.52	130.87	139.47	140
Days Outstanding Inventory (Average Inventory)	31.59	32.09	33.46	37.41	35.56
Average Days Payable Outstanding	49.4	51.38	47.69	51.8	49.69
Cash Conversion Cycle (Average Days)	100.15	110.22	116.65	125.08	125.88
Long Term Solvency
Total Debt/Equity	19.5	25.65	36.49	32.09	39.53
Total Debt / Total Capital	16.32	20.41	26.74	24.29	28.33
LT Debt/Equity	9.29	15.63	27.16	19.81	23.58
Long-Term Debt / Total Capital	7.77	12.44	19.9	14.99	16.9
Total Liabilities / Total Assets	41.23	42.67	46.72	46.07	49.14
EBIT / Interest Expense	247.46	187.53	50.86	42.08	40.44
EBITDA / Interest Expense	305.93	228.98	70.08	59	54.27
(EBITDA - Capex) / Interest Expense	246.19	149.56	52.33	37.24	39.26
Total Debt / EBITDA	1.24	1.52	2.51	2.18	2.27
Net Debt / EBITDA	0.28	0.45	1.35	1.15	1.57
Total Debt / (EBITDA - Capex)	1.55	2.33	3.36	3.45	3.13
Net Debt / (EBITDA - Capex)	0.35	0.68	1.81	1.82	2.16
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	9.3	3.75	5.51	-2.15	9.24
Gross Profit, 1 Yr. Growth %	11.03	11.15	-2.95	8.95	12.7
EBITDA, 1 Yr. Growth %	14.45	14.3	-13.34	4.85	21.18
EBITA, 1 Yr. Growth %	16.32	15.19	-18.47	2.02	23.48
EBIT, 1 Yr. Growth %	17.76	15.72	-23.19	3.02	26.62
Earnings From Cont. Operations, 1 Yr. Growth %	55.4	16.81	-19.06	-11.37	32.1
Net Income, 1 Yr. Growth %	55.05	14.77	-19.93	-9.78	33.89
Normalized Net Income, 1 Yr. Growth %	23.16	15.91	-27.45	11.84	20.62
Diluted EPS Before Extra, 1 Yr. Growth %	55.61	15.4	-18.19	-7.54	36.09
Accounts Receivable, 1 Yr. Growth %	23.24	6.35	6.85	1.31	18.48
Inventory, 1 Yr. Growth %	2.4	6.03	16.63	-0.84	8.04
Net Property, Plant and Equip., 1 Yr. Growth %	5.29	11.93	6.88	7.61	6.69
Total Assets, 1 Yr. Growth %	10.49	8.96	7.9	2.37	8.6
Tangible Book Value, 1 Yr. Growth %	8.56	5.1	-3.3	3.67	1.9
Common Equity, 1 Yr. Growth %	7.18	6.17	-0.06	3.25	2.54
Cash From Operations, 1 Yr. Growth %	-63.58	319.08	-79.24	664.22	-83.67
Capital Expenditures, 1 Yr. Growth %	-30.35	103.03	-36.74	52.68	-9.1
Levered Free Cash Flow, 1 Yr. Growth %	-164.36	-131.01	-784.1	-371.84	-142.1
Unlevered Free Cash Flow, 1 Yr. Growth %	-161.77	-135.06	-691.35	-390.04	-138.68
Dividend Per Share, 1 Yr. Growth %	2.5	14.63	8.51	17.65	5
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	16.32	6.49	4.63	1.61	3.39
Gross Profit, 2 Yr. CAGR %	14.04	11.09	3.86	2.83	10.81
EBITDA, 2 Yr. CAGR %	9.67	14.37	-0.47	-4.68	12.71
EBITA, 2 Yr. CAGR %	8.13	15.76	-3.09	-8.8	12.24
EBIT, 2 Yr. CAGR %	7.46	16.73	-5.72	-11.04	14.21
Earnings From Cont. Operations, 2 Yr. CAGR %	-22.33	34.73	-2.77	-15.3	8.21
Net Income, 2 Yr. CAGR %	-22.44	33.4	-4.13	-15.01	9.9
Normalized Net Income, 2 Yr. CAGR %	8.26	19.48	-8.3	-9.92	16.15
Diluted EPS Before Extra, 2 Yr. CAGR %	-25.3	34.01	-2.84	-13.03	12.18
Accounts Receivable, 2 Yr. CAGR %	14.44	14.48	6.6	4.05	9.56
Inventory, 2 Yr. CAGR %	6.51	4.2	11.21	7.54	3.5
Net Property, Plant and Equip., 2 Yr. CAGR %	7.58	8.56	9.38	7.24	7.15
Total Assets, 2 Yr. CAGR %	8.64	9.72	8.43	5.1	5.44
Tangible Book Value, 2 Yr. CAGR %	5.13	6.82	0.82	0.13	2.78
Common Equity, 2 Yr. CAGR %	4.02	6.67	3.01	1.58	2.89
Cash From Operations, 2 Yr. CAGR %	-29.76	23.55	-6.72	25.97	11.71
Capital Expenditures, 2 Yr. CAGR %	79.07	18.92	13.33	-1.72	17.81
Levered Free Cash Flow, 2 Yr. CAGR %	-40.79	-55.32	45.66	331.24	6.98
Unlevered Free Cash Flow, 2 Yr. CAGR %	-41.36	-53.47	43.98	314.15	5.91
Dividend Per Share, 2 Yr. CAGR %	8.23	8.4	11.53	12.99	11.14
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	22.4	11.97	6.16	2.32	4.09
Gross Profit, 3 Yr. CAGR %	20.5	13.07	6.2	5.53	6.02
EBITDA, 3 Yr. CAGR %	15.58	11.19	4.27	1.27	3.26
EBITA, 3 Yr. CAGR %	13.89	10.43	2.99	-1.41	0.9
EBIT, 3 Yr. CAGR %	12.6	10.14	1.53	-2.89	0.07
Earnings From Cont. Operations, 3 Yr. CAGR %	10.45	-11.02	13.68	-5.72	-1.77
Net Income, 3 Yr. CAGR %	10.37	-11.62	12.53	-6.06	-1.11
Normalized Net Income, 3 Yr. CAGR %	13.65	10.75	1.17	-2.02	-0.71
Diluted EPS Before Extra, 3 Yr. CAGR %	4.77	-13.64	13.68	-4.43	0.97
Accounts Receivable, 3 Yr. CAGR %	30.44	11.68	11.88	4.81	8.65
Inventory, 3 Yr. CAGR %	16.41	6.35	8.19	7.04	7.71
Net Property, Plant and Equip., 3 Yr. CAGR %	21.85	9.01	8	8.78	7.06
Total Assets, 3 Yr. CAGR %	23.08	8.75	9.11	6.37	6.25
Tangible Book Value, 3 Yr. CAGR %	17.05	5.12	3.33	1.76	0.71
Common Equity, 3 Yr. CAGR %	17.59	4.73	4.38	3.09	1.9
Cash From Operations, 3 Yr. CAGR %	-36.66	27.4	-31.82	88.05	-36.25
Capital Expenditures, 3 Yr. CAGR %	40.12	86.73	-3.64	25.17	-4.24
Levered Free Cash Flow, 3 Yr. CAGR %	-38.39	-52.27	10.94	79.33	98.57
Unlevered Free Cash Flow, 3 Yr. CAGR %	-38.86	-50.6	8.59	81.84	87.9
Dividend Per Share, 3 Yr. CAGR %	17.93	10.33	8.44	13.53	10.26
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	14.81	14.76	14.95	7.7	5.04
Gross Profit, 5 Yr. CAGR %	16.21	16.99	13.55	8.85	8.02
EBITDA, 5 Yr. CAGR %	14.71	15.51	8.87	4.55	7.57
EBITA, 5 Yr. CAGR %	14.06	15.13	6.77	2.3	6.6
EBIT, 5 Yr. CAGR %	14.2	15.09	4.88	1.12	6.43
Earnings From Cont. Operations, 5 Yr. CAGR %	14.76	15.65	4.96	-12.76	11.46
Net Income, 5 Yr. CAGR %	14.7	15.03	4.32	-12.99	11.47
Normalized Net Income, 5 Yr. CAGR %	16.12	15.77	4.3	1.97	6.92
Diluted EPS Before Extra, 5 Yr. CAGR %	11.56	11.57	1.66	-13.4	13.08
Accounts Receivable, 5 Yr. CAGR %	17.06	17.76	20.32	8.56	10.95
Inventory, 5 Yr. CAGR %	15.15	13.84	14.3	6.83	6.29
Net Property, Plant and Equip., 5 Yr. CAGR %	13.64	15.4	16.7	8.3	7.66
Total Assets, 5 Yr. CAGR %	15.58	17.08	17	7.27	7.63
Tangible Book Value, 5 Yr. CAGR %	13.79	13.53	10.26	3.09	3.11
Common Equity, 5 Yr. CAGR %	13.62	13.94	11.52	3.46	3.78
Cash From Operations, 5 Yr. CAGR %	3.18	11.24	-26.05	26.83	-16.93
Capital Expenditures, 5 Yr. CAGR %	-3.32	25.52	28.72	44.45	4.42
Levered Free Cash Flow, 5 Yr. CAGR %	-8.63	-24.29	-13.08	15.12	9.34
Unlevered Free Cash Flow, 5 Yr. CAGR %	-8.93	-22.84	-13.88	15.64	7.51
Dividend Per Share, 5 Yr. CAGR %	16.63	15.36	15.33	11.38	9.51